The MXN is around two standard deviations cheap versus oil prices as you can observe in the above chart (based on a weekly regression of FX and oil prices since 2014), while the rest of G10 and EM oil-driven currencies are within 0.5 standard deviations.
The risk premium in the MXN seems related to US politics, and specifically a non-negligible chance that Trump wins in November. Risk premium is not discernible in other currencies or asset classes.
Given the potential sensitivity of the MXN to a Trump victory, the term premium is most noticeable in USD calls. By comparison, the risk premium around the US election is non-existent in other EM currencies.
Selling MXN vol and buying vol in other EM currencies that might come under pressure (KRW, TWD, and TRY) might be worthwhile to consider.
In US election: impact on currency markets we analyse five transmission channels to build an EMFX Trump-vulnerability index.
There is a distinct kink in the MXN vol term structure between the 1m and 3m tenors that straddles the US election (November 8).
EM currencies fear Trump. The ZAR, MXN and MYR have been most sensitive to improvements in Donald Trump’s poll results.
Hence, short AUDMXN to fade US political risk premium and capture MXN being cheap vs. oil and AUD expensive vs. rate differentials (link).


US Economy Fueled by AI Investment Faces Rising Risks Ahead of Fed Meeting
Urban studies: Doing research when every city is different
Lithium Market Poised for Recovery Amid Supply Cuts and Rising Demand
NHS shakeup: if it sounds like we’ve been here before, it’s because we have
Bank of America Posts Strong Q4 2024 Results, Shares Rise
Goldman Sachs Sees Stronger U.S. Dollar as Global Economic Gaps Widen
Moody's Upgrades Argentina's Credit Rating Amid Economic Reforms
AI-Driven Memory Chip Prices May Be Skewing U.S. Inflation Data, Fed Minutes Suggest
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026
Oil Prices Dip Slightly Amid Focus on Russian Sanctions and U.S. Inflation Data
S&P 500 Relies on Tech for Growth in Q4 2024, Says Barclays
JPMorgan Sees Biotech Sector at Turning Point, Upgrades Top Pharma Stocks
European Stocks Rally on Chinese Growth and Mining Merger Speculation
Gold Cracks Below $4,500 as Safe-Haven Shine Fades; Technical Breakdown Signals Sell-on-Rallies Toward $4,000
China’s Growth Faces Structural Challenges Amid Doubts Over Data 



